Patrick G. Gattari
Patrick G. Gattari's practice includes patent procurement, technology transactions, and client counseling in relation to patent enforcement with emphasis in the chemical, pharmaceutical, diagnostic, and biotechnology arts. His practice focuses on counseling clients with respect to patent portfolio management and the development, licensing, acquisition, and sale of intellectual property and technology. His work includes the structuring and negotiation of technology related transactions including collaboration, joint development, consulting and outsourcing agreements, and technology assignments and licenses. He also counsels clients on the intellectual property components of mergers, acquisitions, and venture capital related transactions.
Prior to joining MBHB, Mr. Gattari was patent counsel at Dade Behring, Inc. (now Siemens Healthcare Diagnostics), where his work emphasized patent prosecution and technology transactions. He also worked for Abbott Laboratories in a variety of positions focusing on the development and production of pharmaceuticals and diagnostic devices.
education
J.D., Southern Methodist University Dedman School of Law
B.S., University of Michigan, Cellular and Molecular Biology
bar admissions
Illinois
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the Northern District of Illinois
U.S. District Court for the Northern District of Illinois - Trial Bar
U.S. Patent & Trademark Office
professional leadership
IIT Chicago-Kent College of Law
- Adjunct Professor, Intellectual Property and Technology Licensing
Northwestern University School of Engineering
- Adjunct Professor, Legal Aspects of Engineering
Intellectual Property Law Association of Chicago
- Former Chair, Biotechnology Law Committee
Chicago Bar Association
- Former Chair, Food and Drug Regulatory Law Committee
publications
"Maintaining Confidentiality in Technology Transitions: New Problems with an Old Concept" snippets, Vol. 7, Issue 4, Fall 2009.
"Supreme Court Weighs Patent Rights and Activities Associated With FDA Approval of New Drugs," BioExecutive International, April 2005.
"Determining Inventorship of U.S. Patent Applications" Intellectual Property & Technology Law Journal, Vol. 17, No. 5, 2005.
"Drafting the Technology Game Plan, Part 3: Proper Inventorship Determinations" snippets, Vol. 1, Issue 2, Fall 2003.